SCIENION and Pictor Limited partner to commercialize high-throughput SARS-CoV-2 antibody testing system

The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance

29 Sept 2021
Blake Forman
Content Creator

Industry news

SCIENION, a BICO company, has announced it has entered into a strategic collaboration with diagnostic biotechnology company Pictor Limited to commercialize a high-throughput SARS-CoV-2 antibody testing system. In the collaboration, the two companies will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test to create a platform capable of testing both anti-nucleocapsid and anti-spike antibodies in one reaction. This analysis is an important step in the sustained fight against the pandemic by measuring the population’s level of herd immunity through natural infections and vaccinations.

“As COVID-19 remains a widespread concern, measuring antibody levels across populations will be critical for public health officials to stop new variant surges,” said Holger Eickhoff Ph.D., co-founder, and CEO of SCIENION GmbH. “We’re honored to work with Pictor to help further develop this vital technology.”

The combined system will provide a highly automated miniaturized multiplex immunoassay test in a 96 well plate format capable of providing quick analysis on patients’ level of antibodies. The system also leverages proprietary software, developed by Pictor Ltd. which produces a risk score for individuals to determine their likelihood of carrying a COVID-19 infection.

“We are thrilled to have entered into this strategic collaboration with SCIENION,” said Thomas Schlumpberger, Chief Executive Officer, Pictor Ltd. “Leveraging the sciREADER colorimetric high performance and accuracy enables Pictor to bring high throughput, high performance and low-cost multiplexed antibody testing for SARS-CoV-2 to the market. We are eager to provide insights into the epidemiological spread of the virus to help inform control and prevention measures.”

The PictArray SARS-CoV-2 Serology Test enters clinical trials in September 2021 with the goal of receiving FDA emergency use authorization (EUA) and brought to market in early 2022. The companies also plan to pursue a positive Committee for Medicinal Products for Human Use (CHMP) opinion for use in the United Kingdom and European Union.

For more of the latest science news, straight to your inbox, become a member of SelectScience for free today>>

sciREADER

Scienion

sciREADER - high quality digital imaging of colorimetric and fluorescent assays

(0)

Links

Tags

AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.RNA InterferenceRNA interference (RNAi) uses siRNA or miRNA for transcriptional silencing, gene knockdown and regulation of gene expression. RNAi requires chemical synthesis, introduction of DNA vectors into cells, an assay of RNAi effects and RNAi quantification or analysis. Consider target sequence selection, reagent preparation, controls, high specificity and effectiveness and low non-specific gene knockdown.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.Clinical MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Molecular DiagnosticsMolecular diagnostics use an individual’s genetic code and gene expression to diagnose and monitor diseases. The technique is used increasingly in the field of infectious diseases and oncology, as well as areas such as coagulation, HLA typing and pharmacogenomics. Molecular diagnostics plays a pivotal role in personalized medicine.BiotechnologyBiotechnology is the use of biological processes, organisms, or systems in the production of products and services. It spans a wide range of applications, including healthcare, agriculture, and environmental management. Browse our peer-reviewed product directory to find the best biotechnology tools, compare products, check reviews, and get pricing directly from manufacturers.Covid-19COVID-19, caused by the SARS-CoV-2 virus, has led to a global health crisis with profound impacts on societies and economies. Research into diagnostics, vaccines, treatments, and understanding viral mechanisms continues to evolve. The pandemic has accelerated innovations in healthcare and biopharmaceuticals, including novel vaccine platforms and rapid testing technologies. Browse our peer-reviewed product directory to find top COVID-19 testing kits, research tools, vaccines, and treatments, compare products, read reviews, and receive direct pricing from manufacturers.